TAKEDA PARTNERS WITH WESTWOOD & WILSHIRE TO FILL MEDICAL DIRECTOR OF CLINICAL DEVELOPMENT- NOROVIRUS

Guy De la Rosa, MD, has joined Takeda as their new Medical Director of Clinical Development - Norovirus. Dr. De la Rosa joins Takeda from Janssen R&D, where he served as the Medical Leader-Lumicitabine. Dr. De la Rosa has held positions of increasing related responsibility at Tibotec Therapeutics, Abbott Laboratories, and Iowa Methodist Medical Center throughout his career.

The search was successfully led by Julie McDonald at Westwood & Wilshire.

At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Based in Los Angeles, California with additional offices in Silicon Valley, we serve our clients on a local, national and global basis.

Previous
Previous

BAXTER PARTNERS WITH WESTWOOD & WILSHIRE TO FILL SENIOR DIRECTOR GLOBAL REGULATORY AFFAIRS LEAD, GENERIC PHARMACEUTICALS

Next
Next

AGIOS PHARMACEUTICALS PARTNERS WITH WESTWOOD & WILSHIRE TO FILL ASSOCIATE MEDIAL DIRECTOR